Tanenbaum Keale LLP partner John Fitzpatrick will provide an update on asbestos litigation involving the U.S. Navy during a presentation at this week’s Defense Research Institute (DRI) Asbestos Medicine Seminar in Las Vegas. He goes on stage Thursday to share key insights and relevant updates based on active and recently resolved matters.

The DRI Asbestos Medicine Seminar brings together a notable lineup of medical and scientific experts and top-tier litigators to discuss a broad range of topics in an effort to promote insightful discussions on legal defense strategies and provide meaningful networking opportunities.

DRI is the leading organization of defense attorneys and in-house counsel providing access to resources for attorneys serving clients and corporations in all types of litigation, including asbestos.

With a nationally renowned private practice spanning decades, Fitzpatrick’s diverse track record in litigation ranges from complex, high-stakes class action and toxic tort lawsuits to product liability cases often involving latent diseases, catastrophic injuries or death. In a distinguished legal career spanning more than four decades, he has tried more than 200 cases to verdict in 40 different states and has delivered complete defense verdicts for his clients in the vast majority.